Researchers at UCL Institute of Ophthalmology, University College London, and Moorfields Eye Hospital NHS Foundation Trust, UK, have reported a study on CNG3A-associated achromatopsia (ACMH),… Read More »CNGA3-associated ACHM displays stable foveal cone structure over time, presenting an attractive therapeutic opportunity for treatment.
Sept. 19th, 2024 – On the first day of the EURETINA Congress in Barcelona, Prof. Anat Loewenstein, President of EURETINA was delighted to announce the… Read More »EURETINA announce the inaugural Ramin Tadayoni Award for Dr. Andrea Govetto, MD, PhD, based in Milan, Italy.
Researchers at Moorfields Eye Hospital, the UCL Institute of Ophthalmology, University College London and the Shiley Eye Institute, University of California, San Diego, has reported… Read More »Variants on the TMEM216 gene suggests an under-reporting from certain ancestry cohorts on non-syndromic retinitis pigmentosa (RP).
Researchers at the Department of Ophthalmology, Boston Children’s Hospital, and the Harvard Medical School, have reported that the interface of photoreceptors and RPE in Stargardt… Read More »Analysis of data from AO-SLO images on Stargardt disease patients show clear profiles of hyper-reflective bands, potentially targeted for pharmaceutical treatment.
In a recent study published in the prestigious journal Nature Communications (2024 Jul 21;15[1]:6150), researchers have reported that an upstream regulator, “AKT2” (a member of… Read More »Researchers identify that lysosomal biogenesis and mitochondrial signalling may suggest new therapeutic targets for dry-AMD.
Researchers at the School of Pharmacy, University of Eastern Finland, and the Gavin Herbert Eye Institute-Center for Translational Vision Research, Department of Ophthalmology, University of… Read More »Re-purposed drugs for retinitis pigmentosa may address mutation-independent approach for retinal degenerations.
Researchers based at the Nuffield Department of Clinical Neurosciences, The John Radcliffe Hospital, University of Oxford, have reported a new study on the mechanism of… Read More »AAV treatment or surgical issues on chorioretinal atrophy? Researchers report on a study on potential adverse events in a gene therapy treatment.
Researchers based at the Department of Biomedical Engineering, University of Houston, Texas and the Department of Ophthalmology, Duke University Medical Centre, Durham, North Carolina, have… Read More »Maintaining proper RHO:PRPH2 ratios in photoreceptors may provide a potential therapeutic approach for intervention.
Researchers based at the MRC Human Genetics Unit, at the University of Edinburgh, and the Western General Hospital (Edinburgh), have reported a new study indicating… Read More »X-linked retinitis pigmentosa (XLRP) due to RPGR variants report new data on actin dynamics.
A consortium of researchers across Australia, New Zealand, USA, Italy, Portugal, Singapore, Netherlands, Taiwan and Canada, have reported a new study evaluating clinical, electrophysiological and… Read More »Variants in peripherin 2 (PRPH2 gene) shows genetic, functional and clinical observations on 241 IRD patients.
